100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Pharmacology- Neuropharmacology Questions & Answers $12.99   Add to cart

Exam (elaborations)

Pharmacology- Neuropharmacology Questions & Answers

 0 view  0 purchase
  • Course
  • Pharmacology- Neuropharmacology
  • Institution
  • Pharmacology- Neuropharmacology

Aspirin vs other NSAIDS - ANSWERaspirin- orginal NSAID- others were developed to improve efficacy and decrease toxicity/ ADEs aspirin causes IRREVERSIBLE inactivation of COX-1 = production of thromboxane for the LIFE of the platelet k others: have reversible inactivation of cyclooxyrgenase (l...

[Show more]

Preview 2 out of 6  pages

  • September 20, 2024
  • 6
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • Pharmacology- Neuropharmacology
  • Pharmacology- Neuropharmacology
avatar-seller
Brilliantscores1
Pharmacology- Neuropharmacology
Questions & Answers
Aspirin vs other NSAIDS - ANSWERaspirin- orginal NSAID- others were developed to
improve efficacy and decrease toxicity/ ADEs

aspirin causes IRREVERSIBLE inactivation of COX-1 = production of thromboxane for
the LIFE of the platelet k

others: have reversible inactivation of cyclooxyrgenase (lasting only for duration of drug
activity)

NSAID Cox 1 & 2 MOA - ANSWERNSAIDS: decrease sensitivity of vessels to
bradykinin and histamine, affect T lymphocytes and reverse vasodilation of inflammation

all (except COX 2 selective agents) inhibit platelet aggregation

COX 2 selective inhibitors (coxibs) inhibit prostaglandin synthensis at sight of
inflammation w/o affecting COX1

NSAID effects - ANSWERanalgesic, anti inflammatory, and antipyretic

-all except cox 2 selective also inhibit platelet aggregation (those inhibit prostaglandin
synthesis

NSAID indications - ANSWERmild-mod pain secondary to soft tissue injury, athletic
injury, dental pain, minor surgery, OA, RA, dysmenorrhea, Gout

-not all indicated for all rheumatic diseases- most likely effective in rheumatic arthritis,
psoriatic arthritis and arthritis assoc w/ inflammatory bowel disease

Osteoarthritis pathophysiology - ANSWERdegeneration of articular cartilge
body attempts to repair, compensates, hypertrophy at articular margins, forms spurs,
thickening of synovial membranes
low levels of inflamation

Osteoarthritis pharm treatment - ANSWERpharm: acetominophen BID, NSaids, COX-2
inhibitors, intraatricular injection of steroids

nonpharm: proper exercise w/ rest periods, weight loss in overweight pts

Gout Pathophysiology - ANSWERinflammatory response to monosodium urate crysatls
in tissues. Distal joints usually affected, crystals can be any size in any tissue and

, present as otphaceous gout or urate neuropathy if crystalization is localized in renal
medulla

tophi- crystals of urate precipitate in joints

Gout pharm treatment - ANSWERpreventative: 1st line: colchicine; 2nd line: urocosuric
drug if uric acid under excreted, allopurinol or febuxostate if uric acid overproduced

acute attack: NSAIDS (indomethacin most frequently, naproxen), corticosteroids,
colcichine

Colchicine - ANSWER1st line treatment for prevention of gout-

exact MOA Unknown- decreases deposition of uric crystals, reduction of inflammatory
response- does NOT affect uric acid metabolism, NOT an analgesic

ADEs: N/V, abd pain, diarrhea
- geriatrics: GI toxicities in up to 80% of geriatrics, bone marrow suppression, bloody
dyscrasisis, hepatic necrosis, and seizures possible
-preg category C

Drug interactions: enhanced effects of CNS depressants and sympathomimetic agents;
may interfere w/ vit. B12 absorption(concern if using chronically), increased toxicity if
used w/ clarithomycin, erythromycin and grapefruit juice; cyclosporine levels are
increased

monitoring-
-1st time users: monitor weekly for signs of toxicity
-3-6month blood counts if long-term therapy
-may cause reversible malabsorption of B12- periodic monitoring recommended
-LFTs q 2-3 months

Xanthine Oxidase Inhibitors - ANSWERAllopurinol and Febuxostat(newer, more
expensive)

used in chronic gout (not in acute attack)

MOA: decrease concentration of less soluble uric acid: decreases precipitation of uric
acid crystals in joints and tissues

contraindications: not given during an acute attack- usually w/held for 1-2 after acute
attack and given w/ colchicine or NSAID to avoid an attack

allopurinol - ANSWERa xanthine oxidase inhibitor-see that term

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Brilliantscores1. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $12.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

77764 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$12.99
  • (0)
  Add to cart